HTR1A and serotonin syndrome: As previous studies have shown that repeated doses of 8-OH-DPAT could reduce the serotonin syndrome through desensitization of postsynaptic 5-HT1A receptors [23, 32], our study confirmed the prior findings by showing that chronic administration of 8-OH-DPAT did not lead to hyperactive behavior in the open-field in sham rats.